These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15029272)

  • 21. Idiopathic pulmonary hypertension causing acquired von Willebrand disease and menorrhagia.
    Sokkary NA; Dietrich JE; Venkateswaran L
    J Pediatr Adolesc Gynecol; 2011 Oct; 24(5):e107-9. PubMed ID: 21715195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Von Willebrand Disease and Pregnancy: A Review of Evidence and Expert Opinion.
    Reynen E; James P
    Semin Thromb Hemost; 2016 Oct; 42(7):717-723. PubMed ID: 27648611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical diagnosis of von Willebrand disease.
    Federici AB
    Haemophilia; 2004 Oct; 10 Suppl 4():169-76. PubMed ID: 15479393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, economic, and health-related quality of life burden associated with von Willebrand disease in adults and children: Systematic and targeted literature reviews.
    Castaman G; Katsarou O; Jansen N; Santos S; Escolar G; Berntorp E
    Haemophilia; 2023 Mar; 29(2):411-422. PubMed ID: 36097135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current understanding of von Willebrand's disease in women - some answers, more questions.
    Kouides PA
    Haemophilia; 2006 Jul; 12 Suppl 3():143-51. PubMed ID: 16684010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gynaecological and obstetric management of women with inherited bleeding disorders.
    Demers C; Derzko C; David M; Douglas J;
    Int J Gynaecol Obstet; 2006 Oct; 95(1):75-87. PubMed ID: 17106950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-utility analysis of von Willebrand disease screening in adolescents with menorrhagia.
    Sidonio RF; Smith KJ; Ragni MV
    J Pediatr; 2010 Sep; 157(3):456-60, 460.e1. PubMed ID: 20447646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnosis, natural history, and management of von Willebrand disease in women in the age of guidelines.
    Kalvehalli Kashinath S; Kouides PA
    Expert Rev Hematol; 2023 Jun; 16(6):435-450. PubMed ID: 36609196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bleeding disorders in premenopausal women: (another) public health crisis for hematology?
    James AH; Ragni MV; Picozzi VJ
    Hematology Am Soc Hematol Educ Program; 2006; ():474-85. PubMed ID: 17124102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. von Willebrand factor activity and activated partial thromboplastin time as proxy biomarkers for coagulopathies in women with menorrhagia in Zambia: a case-control study.
    Munsanje MM; Kaile T; Kowa S; Sinkala M; Simakando M; Ndhlovu J; Chiluba BC
    Pan Afr Med J; 2021; 39():13. PubMed ID: 34394804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
    Michiels JJ; van Vliet HH
    Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The condensed MCMDM-1 VWD bleeding questionnaire as a predictor of bleeding disorders in women with unexplained menorrhagia.
    Azzam HA; Goneim HR; El-Saddik AM; Azmy E; Hassan M; El-Sharawy S
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):311-5. PubMed ID: 22450545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey.
    Kouides PA; Phatak PD; Burkart P; Braggins C; Cox C; Bernstein Z; Belling L; Holmberg P; MacLaughlin W; Howard F
    Haemophilia; 2000 Nov; 6(6):643-8. PubMed ID: 11122390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring Therapy during Treatment of von Willebrand Disease.
    Favaloro EJ; Pasalic L; Curnow J
    Semin Thromb Hemost; 2017 Apr; 43(3):338-354. PubMed ID: 27472426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis.
    James AH; Konkle BA; Kouides P; Ragni MV; Thames B; Gupta S; Sood S; Fletcher SK; Philipp CS
    Haemophilia; 2015 Jan; 21(1):81-7. PubMed ID: 25333737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menorrhagia and bleeding disorders in adolescent females.
    Halimeh S
    Hamostaseologie; 2012; 32(1):45-50. PubMed ID: 22127528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology, diagnosis, and management of von Willebrand disease in India.
    Ghosh K; Shetty S
    Semin Thromb Hemost; 2011 Jul; 37(5):595-601. PubMed ID: 22102205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Von Willebrand's disease in the IX Region of Chile].
    Cabrera ME; Artigas CG; Páez E; Monsalve V; Zolezzi P; Arauco G; Espinoza R; Hevia C; Villegas J
    Rev Med Chil; 1989 Apr; 117(4):423-30. PubMed ID: 2519397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of inherited bleeding disorders in women with menorrhagia.
    Kadir RA; Economides DL; Sabin CA; Owens D; Lee CA
    Lancet; 1998 Feb; 351(9101):485-9. PubMed ID: 9482440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspects of the laboratory identification of von Willebrand disease in women.
    Kouides PA
    Semin Thromb Hemost; 2006 Jul; 32(5):480-4. PubMed ID: 16862520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.